The active ingredient in Ozempic is semaglutide, a lab-made version of a hormone your body already produces called GLP-1 (glucagon-like peptide-1). Semaglutide shares 94% of its structure with the natural human hormone, but it’s been engineered to last much longer in your bloodstream. That durability is what makes a once-weekly injection possible and what drives the drug’s weight loss effects.
What GLP-1 Does Naturally
Your gut releases GLP-1 after you eat. The hormone does a few things at once: it signals your pancreas to release insulin, tells your liver to stop producing extra sugar, and communicates with your brain that you’ve had enough food. The problem is that natural GLP-1 breaks down within minutes. Your body has an enzyme that chews it up almost immediately, so the effects are short-lived.
Semaglutide is designed to resist that breakdown. It activates the same GLP-1 receptors throughout your body but keeps doing so for days instead of minutes. That sustained signal is what produces noticeable changes in appetite, digestion, and blood sugar regulation.
How Semaglutide Changes Appetite
The most powerful weight loss mechanism is what happens in the brain. Semaglutide activates GLP-1 receptors in areas that control hunger and reward, and it does this more robustly than older drugs in the same class. People on semaglutide consistently describe something specific: the persistent, overwhelming drive to eat food simply fades. This shift often starts shortly after beginning treatment.
Research on people taking semaglutide shows significant reductions in both uncontrolled eating and emotional eating. These aren’t just willpower changes. The drug appears to alter how your brain processes food cues and cravings at a neurological level, making it genuinely easier to eat less without feeling like you’re fighting hunger all day.
The Stomach-Slowing Effect
Semaglutide also slows down how quickly food leaves your stomach, which keeps you feeling full longer after meals. This effect is real but more modest than many people assume. A meta-analysis of studies measuring gastric emptying found that GLP-1 drugs delayed stomach emptying by roughly 36 minutes for solid food, with no significant delay for liquids.
That 36-minute difference matters for satiety, but researchers have noted that the weight loss from semaglutide is likely too large to be explained by slower digestion alone. The brain-based appetite suppression and metabolic changes appear to be doing most of the heavy lifting.
Insulin, Glucagon, and Blood Sugar
Semaglutide’s original purpose, and the reason Ozempic was developed, is blood sugar control. When you eat and your blood sugar rises, semaglutide amplifies your pancreas’s insulin response, helping cells absorb glucose more efficiently. At the same time, it suppresses glucagon, a hormone that tells your liver to release stored sugar into the blood. Less glucagon means less unnecessary glucose floating around.
This matters for weight loss because chronically high insulin and blood sugar levels promote fat storage. By improving how your body handles glucose, semaglutide helps shift your metabolism away from storing energy and toward using it. The insulin response is glucose-dependent, meaning it ramps up when blood sugar is high and backs off when it’s normal, which reduces the risk of dangerous blood sugar drops.
How Much Weight People Lose
In the SUSTAIN FORTE trial, people with type 2 diabetes on the higher 2 mg dose of semaglutide lost an average of 6.9 kg (about 15 pounds) over 40 weeks, compared to 6.0 kg on the 1 mg dose. A real-world study comparing the 0.5 mg and 1 mg doses found nearly identical weight loss at 12 months: around 6.1 to 6.2 kg for both groups.
These numbers reflect Ozempic’s use in people with type 2 diabetes, where weight loss is a secondary benefit. Wegovy, which contains the same semaglutide molecule at a higher dose (2.4 mg), is the version specifically approved for weight management and produces larger losses. Ozempic itself is FDA-approved only for blood sugar control and cardiovascular risk reduction in adults with type 2 diabetes.
What Else Is in the Injection
Beyond semaglutide, each milliliter of Ozempic solution contains a short list of inactive ingredients that keep the drug stable and safe for injection:
- Disodium phosphate dihydrate (1.42 mg): a buffer that maintains the solution’s pH near 7.4
- Propylene glycol (14 mg): a stabilizer commonly used in injectable medications
- Phenol (5.5 mg): a preservative that prevents bacterial growth in the pen
- Water for injection: the base liquid
Small amounts of hydrochloric acid or sodium hydroxide may also be added during manufacturing to fine-tune the pH. None of these inactive ingredients contribute to the drug’s weight loss effects. Semaglutide is doing all the work.